Nootropics – BEHEMOTH LABZ

PRL-8-53

Zeeshan Tariq — Thu, 01 Oct 2026 17:05:28 +0000

Buy PRL-8-53 Online

PRL-8-53 is a synthetic research compound that attracted interest because of its potential effects on memory and learning. Its evidence base is unusually limited, with one small controlled human study published in 1978 and little subsequent clinical research.

Product Information

The original human investigation evaluated PRL-8-53 in a double-blind, placebo-controlled design using a verbal-learning and memory task. The study reported improved retention of verbal information, while visual reaction time and motor control did not show significant changes. No substantial modern clinical development program followed.

How It Works

The precise mechanism of PRL-8-53 has never been adequately established. Early pharmacological research proposed effects involving cholinergic and catecholaminergic systems, but modern mechanistic and clinical evidence remains sparse.

POTENTIAL BENEFITS

1. Memory Research

The strongest human evidence for PRL-8-53 comes from the original controlled study, which reported improved retention of verbal information. This remains the main reason the compound continues to attract cognitive research interest.

2. Learning Research

The original study examined acquisition and retention using verbal-learning tasks. The reported findings provide a narrow but measurable basis for investigating PRL-8-53 in memory research.

3. Cognitive-Pharmacology Research

PRL-8-53 provides an example of a compound whose early cognitive findings were promising enough to attract continued interest despite the absence of a modern development program.

4. Nootropic Research

The compound remains relevant to research into small molecules capable of influencing memory without producing broad motor-performance effects. However, the evidence base is far smaller than that of established cognitive medicines.

Dosage

The original human study used a single 5 mg oral dose of PRL-8-53. This was a small early study and does not establish a modern therapeutic dose or long-term dosing protocol.

Side Effects

The published human evidence is too limited to define a reliable long-term safety profile. The original study did not establish the safety data needed to support chronic use.

References

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Melts Brain-Fuel Dissolving Strips

Zeeshan Tariq — Thu, 01 Oct 2026 17:05:25 +0000

Buy Melts Brain-Fuel Dissolving Strips Online

Melts Brain-Fuel dissolving strips are fast-dissolving oral films formulated with paraxanthine, L-theanine, Alpha-GPC, huperzine A, vinpocetine, and B vitamins. The formulation is designed around mental alertness, focused energy, and cognitive-wellness research.

Product Information

The product is supplied as individually sealed dissolving strips intended to dissolve in the mouth without water. Its ingredient profile combines a caffeine metabolite, amino-acid derivative, choline compound, plant alkaloid, vincamine derivative, and B vitamins. The manufacturer describes the strips as a portable alternative to conventional capsules or powders.

How It Works

The formulation combines several mechanisms: paraxanthine provides adenosine-receptor activity, L-theanine is associated with relaxation and attention research, Alpha-GPC supports cholinergic signaling, and huperzine A inhibits acetylcholinesterase. B vitamins contribute to normal energy metabolism.

POTENTIAL BENEFITS

1. Mental-Alertness Research

Paraxanthine is the principal active stimulant-related component of the formulation and is studied as a caffeine metabolite with effects on adenosine signaling. This gives the strips their primary alertness-oriented research profile.

2. Focus & Attention Research

L-theanine and Alpha-GPC have both been studied in relation to attention and cognitive performance. Their inclusion creates a formulation aimed at combining alertness with a calmer cognitive profile.

3. Cholinergic Research

Alpha-GPC supplies choline for acetylcholine-related pathways, while huperzine A inhibits acetylcholinesterase. Together, these ingredients provide a clear cholinergic research component.

4. Convenient Oral Delivery

The dissolving-film format is designed for rapid oral disintegration without water. This makes the formulation portable and convenient compared with conventional tablets or capsules.

Dosage

The product is supplied as 30 individually sealed strips, but the appropriate daily use depends on the manufacturer's current product directions and the specific formulation. Because the blend contains multiple active ingredients, dosing data for individual ingredients should not be combined into a separate homemade dosing protocol.

Side Effects

Potential effects depend on the ingredients and individual sensitivity. Stimulant-related ingredients may cause jitteriness, headache, or sleep disturbance, while huperzine A and vinpocetine can produce additional pharmacological effects and drug interactions.

References

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Bromantane Powder

Zeeshan Tariq — Fri, 11 Sep 2026 16:12:39 +0000

Buy Bromantane Powder Online

Bromantane is an adamantane-derived actoprotector developed in Russia and investigated for its ability to support physical and mental performance under demanding conditions. It has also been studied for psychophysiological effects and fatigue resistance.

Product Information

Bromantane belongs to the actoprotector class, compounds designed to improve resistance to physical stress without simply producing conventional stimulant effects. Human and animal research has investigated its effects on functional performance, fatigue, and adaptation.

How It Works

Bromantane appears to influence several central and metabolic pathways involved in adaptation and performance. Its pharmacology is distinct from classic stimulants, with research suggesting effects on dopaminergic systems and adaptive responses to stress.

POTENTIAL BENEFITS

1. Supports Physical Performance

Bromantane was developed as an actoprotector intended to improve physical work capacity and resistance to demanding conditions. Research has investigated its effects during fatigue, heat, hypoxia, and other physical stressors.

2. Supports Fatigue Resistance

One of Bromantane's defining research characteristics is its ability to improve performance under conditions associated with fatigue. Animal studies have demonstrated increased working capacity and improved recovery from experimentally induced fatigue.

3. Mental Performance Research

Human research has examined Bromantane's influence on EEG and psychophysiological performance, including studies in healthy volunteers showing favorable effects on functional state.

4. Adaptation to Environmental Stress

Bromantane has been studied under challenging environmental conditions such as heat and hypoxia. Historical human research reported improved resistance to combined environmental stressors following oral administration.

Dosage

Historical human research has included 250 mg orally in healthy volunteers and in environmental-stress experiments. These are study-specific historical doses rather than a modern standardized therapeutic regimen.

Side Effects

Potential effects may include stimulation, insomnia, headache, changes in mood, gastrointestinal symptoms, or alterations in blood pressure and heart rate. Long-term safety information outside historical clinical use is limited.

References

Kim H, et al. The pharmacology of actoprotectors: practical application for improvement of mental and physical performance. Pharmacol Ther. 2013. PMID: 24009833. PubMed
Viatleva OA, et al. The neuro- and psychophysiological effects of bromantane. Voen Med Zh. 2000. PMID: 10998997. PubMed
Sedov AV, et al. Experimental rationale for the use of drugs to increase the resistance of the human body to the combined action of carbon monoxide and hyperthermia. Med Tr Prom Ekol. 1993. PMID: 8087458. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Noopept (Omberacetam) Powder

Zeeshan Tariq — Fri, 11 Sep 2026 16:12:38 +0000

Buy Noopept (Omberacetam) Powder Online

Noopept, also known as Omberacetam or GVS-111, is a synthetic proline-containing dipeptide ester developed as a potent nootropic compound. It has been investigated for memory, cognitive impairment, neuroprotection, and adaptation to physical stress.

Product Information

Noopept has been studied in Russian clinical literature as a cognitive and neuroprotective agent. Human studies have used 10-20 mg/day, while preclinical research has explored mechanisms involving neurotrophic signaling, oxidative stress, inflammation, and glutamate-related neurotoxicity.

How It Works

Noopept appears to influence multiple neuronal pathways rather than acting through a single receptor. Research has associated it with neurotrophic signaling, antioxidant activity, modulation of glutamate-related toxicity, and effects on memory consolidation and retrieval.

POTENTIAL BENEFITS

1. Supports Memory Research

Noopept has been investigated for memory acquisition, consolidation, and retrieval. Human clinical research has reported improvements in selected cognitive measures in people with cognitive impairment.

2. Neuroprotective Research

Preclinical research has reported protection against ischemic and excitotoxic neuronal damage. These findings have contributed to Noopept's reputation as a neuroprotective as well as nootropic compound.

3. Cognitive-Function Support

Clinical studies have examined Noopept in patients with cognitive impairment associated with stroke, vascular disease, and trauma. A published study used 20 mg/day for two months and reported improved cognitive measures.

4. Anxiolytic and Adaptogenic Research

Noopept has also been investigated for anxiety-related effects and adaptation to environmental stress. Human volunteer research reported effects on psychological and physical performance under challenging environmental conditions.

Dosage

Published human studies have used 10 mg twice daily (20 mg/day), including a clinical study involving patients with stroke-related cognitive impairment. Earlier clinical-development literature also describes 5 mg and 10 mg tablet strengths. These doses reflect historical clinical research rather than a recommendation for unsupervised use.

Side Effects

Reported clinical studies suggest relatively good short-term tolerability, but possible headache, irritability, sleep changes, gastrointestinal effects, or other CNS symptoms may occur. Long-term safety data remain limited, especially outside the populations studied clinically.

References

Gudasheva TA, et al. The original novel nootropic and neuroprotective agent noopept. Eksperimental'naia i klinicheskaia farmakologiia. 2002. PMID: 12596521. PubMed
Amelin AV, Iliukhina AIu, Shmonin AA. Noopept in the treatment of mild cognitive impairment in patients with stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(10 Pt 1):44-46. PMID: 22500312. PubMed
Shabanov PD, Ganapol'skii VP, Aleksandrov PV. Meteoadaptogenic properties of peptide drugs in healthy volunteers. Eksperimental'naia i klinicheskaia farmakologiia. 2007;70(6):41-47. PMID: 18318195. PubMed
Szeleszczuk L, et al. Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept). 2024. PMID: 39298839. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

NSI-189 Free Base Powder

Zeeshan Tariq — Fri, 11 Sep 2026 16:12:37 +0000

Buy NSI-189 Free Base Powder Online

NSI-189 Free Base is the non-phosphate form of NSI-189, a small-molecule compound developed to investigate neurogenesis and hippocampal function. The active NSI-189 molecule is the basis of the clinical research conducted with its phosphate salt.

Product Information

The clinical development of NSI-189 primarily used NSI-189 phosphate, including Phase 1B and Phase 2 randomized trials. The free-base form represents the same active molecular entity without the phosphate salt, but its pharmacokinetic and formulation characteristics should not automatically be assumed identical.

How It Works

NSI-189 was developed as a neurogenic compound intended to influence neuronal growth and hippocampal function. Unlike traditional antidepressants, its proposed activity does not center on direct monoamine reuptake inhibition.

POTENTIAL BENEFITS

1. Neurogenesis Research

NSI-189 is particularly notable for its focus on neurogenesis and hippocampal biology. This mechanism has made it an important research compound for investigating how neuronal growth may influence cognition and mood.

2. Cognitive Research

Clinical trials included cognitive and physical-functioning assessments, with some exploratory improvements observed during early development.

3. Mood-Related Research

NSI-189 was investigated in patients with major depressive disorder. Although Phase 2 results did not establish superiority on the primary depression endpoint, some secondary outcomes showed potential activity.

4. Hippocampal Function

The compound's development was based in part on the relationship between hippocampal neurogenesis and cognitive and emotional function, giving NSI-189 a distinctive neuroscience research profile.

Dosage

Published human trials used NSI-189 phosphate, not a separately validated free-base dosing protocol. Phase 2 studies tested 40 and 80 mg/day of the phosphate form. These doses should not automatically be treated as equivalent dosing for a free-base formulation.

Side Effects

The human safety profile is limited to clinical development of NSI-189 phosphate. Potential CNS and systemic adverse effects remain incompletely characterized for separately formulated free-base material.

References

Fava M, et al. A Phase 1B, randomized, double blind, placebo-controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Mol Psychiatry. 2016;21(10):1372-1380. PMID: 26643541. PubMed
Papakostas GI, et al. A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder. Mol Psychiatry. 2020;25(7):1569-1579. PMID: 30626911. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

NSI-189 Phosphate Powder

Zeeshan Tariq — Fri, 11 Sep 2026 16:12:36 +0000

Buy NSI-189 Phosphate Powder Online

NSI-189 Phosphate is a small-molecule neurogenic compound developed to investigate hippocampal neurogenesis and cognitive and mood-related disorders. It progressed through human clinical trials in major depressive disorder.

Product Information

NSI-189 was evaluated in randomized controlled clinical studies using oral doses of 40 and 80 mg/day. Phase 1B research suggested potential effects on depressive and cognitive measures, while the subsequent Phase 2 trial did not significantly improve its primary depression endpoint.

How It Works

NSI-189 was designed to influence neurogenesis, particularly within the hippocampus. Its mechanism differs from traditional antidepressants because it does not primarily depend on monoamine reuptake inhibition.

POTENTIAL BENEFITS

1. Neurogenesis Research

NSI-189 was developed specifically around the concept of stimulating neuronal growth and hippocampal neurogenesis, making it a distinctive compound in neuroscience research.

2. Cognitive Function Research

Human studies included cognitive and physical-functioning assessments, with Phase 1B research reporting exploratory improvements in selected cognitive measures.

3. Mood Research

NSI-189 progressed into clinical trials for major depressive disorder. Although the primary Phase 2 depression endpoint was not statistically significant, several secondary measures showed signals of potential activity.

4. Non-Monoaminergic Approach

NSI-189's proposed neurogenic mechanism differentiates it from conventional antidepressants that primarily target serotonin, norepinephrine, or dopamine reuptake.

Dosage

Human Phase 1B research evaluated 40 mg once daily, 40 mg twice daily, and 40 mg three times daily. A later Phase 2 trial evaluated 40 mg/day and 80 mg/day for 12 weeks. These are clinical-trial doses rather than an established current treatment regimen.

Side Effects

Clinical trials reported generally acceptable short-term tolerability, although adverse events occurred. Because NSI-189 has not become an established mainstream therapy, long-term safety and broader drug-interaction data remain limited.

References

Fava M, et al. A Phase 1B, randomized, double blind, placebo-controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Mol Psychiatry. 2016;21(10):1372-1380. PMID: 26643541. PubMed
Papakostas GI, et al. A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder. Mol Psychiatry. 2020;25(7):1569-1579. PMID: 30626911. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Dihexa Powder

Zeeshan Tariq — Fri, 11 Sep 2026 16:12:35 +0000

Buy Dihexa Powder Online

Dihexa is a small-molecule analog derived from angiotensin IV research and developed as a blood-brain-barrier-penetrant HGF/c-Met pathway modulator. It has attracted substantial interest because of its reported effects on synaptic formation and cognitive performance in animal models.

Product Information

Research has shown that Dihexa binds hepatocyte growth factor (HGF), enhances HGF-dependent c-Met signaling, and promotes hippocampal spinogenesis and synaptogenesis. Oral Dihexa has also demonstrated procognitive effects in animal models.

How It Works

Dihexa interacts with HGF and enhances signaling through the c-Met receptor. This pathway is involved in neuronal growth, synaptic development, and cellular repair, providing the mechanistic basis for Dihexa's cognitive research profile.

POTENTIAL BENEFITS

1. Synaptogenesis Research

Dihexa has demonstrated the ability to promote hippocampal spinogenesis and synaptogenesis in experimental systems. These effects make it particularly interesting in research focused on forming and strengthening neuronal connections.

2. Cognitive Performance Research

Orally administered Dihexa has produced procognitive effects in animal models, including improvements in spatial-learning tasks. This is one of the compound's most notable research characteristics.

3. Neuroplasticity Research

By influencing HGF/c-Met signaling, Dihexa may affect pathways involved in neuronal growth and structural plasticity. This gives it a broader research profile than compounds acting solely as acute stimulants.

4. Blood-Brain-Barrier Penetration

Dihexa was specifically developed to overcome the blood-brain-barrier limitations associated with earlier angiotensin-derived molecules, allowing it to reach central nervous system targets in experimental models.

Dosage

There is no established human dosage for Dihexa. Research doses in animal and cellular models should not be interpreted as human therapeutic dosing.

Side Effects

Human safety data are very limited. Because HGF/c-Met signaling regulates growth, differentiation, and tissue remodeling, unintended effects from sustained pathway activation remain an important research concern.

References

McCoy AT, et al. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. J Pharmacol Exp Ther. 2014;349(2):286-293. PMID: 25187433. PubMed
Mizuno S, Nakamura T. The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease. Front Pharmacol. 2015. PMID: 25649658. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

7,8-Dihydroxyflavone Powder

Zeeshan Tariq — Fri, 11 Sep 2026 16:12:34 +0000

Buy 7,8-Dihydroxyflavone Powder Online

7,8-Dihydroxyflavone (7,8-DHF) is a flavone derivative best known for its activity at the TrkB receptor, the principal receptor for brain-derived neurotrophic factor (BDNF). It has become a prominent research compound in neuroscience and neuroprotection.

Product Information

Preclinical research has shown that 7,8-DHF can activate TrkB and downstream signaling pathways associated with neuronal survival, differentiation, and synaptic plasticity. Studies have examined its effects in models of neurodegeneration, stroke, Parkinsonism, and cognitive dysfunction.

How It Works

7,8-DHF binds to and activates TrkB, mimicking certain signaling effects normally produced by BDNF. TrkB activation can influence neuronal survival, synaptic plasticity, and neurotrophic signaling.

POTENTIAL BENEFITS

1. Supports Neurotrophic Signaling

7,8-DHF directly activates TrkB-related signaling, making it particularly interesting for research into BDNF-associated neuronal function.

2. Memory and Cognitive Research

Animal studies have reported improvements in memory-related behavior following 7,8-DHF administration, supporting its investigation as a potential cognitive research tool.

3. Neuroprotective Potential

7,8-DHF has protected neurons in several experimental models, including models involving excitotoxicity, ischemic injury, and dopaminergic degeneration.

4. Synaptic Plasticity Research

TrkB activation is closely associated with synaptic remodeling and plasticity. Research has demonstrated that 7,8-DHF can promote signaling linked to synaptogenesis and neuronal maturation.

Dosage

There is no established human therapeutic dosage for 7,8-DHF. Published doses are primarily from cellular and animal experiments and should not be treated as validated human dosing.

Side Effects

Human safety data are limited. Because TrkB signaling influences numerous neuronal and cellular processes, the consequences of sustained pharmacological activation remain incompletely characterized.

References

Liu X, et al. Biochemical and biophysical investigation of the brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone in the binding and activation of the TrkB receptor. J Biol Chem. 2014;289(40):27571-27584. PMID: 25143381. PubMed
Jang SW, et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci USA. 2010;107(6):2687-2692. PMID: 20133810. PubMed
Liu C et al. 7,8-dihydroxyflavone protects 6-OHDA and MPTP induced dopaminergic neuron degeneration through activation of TrkB in rodents. Neurosci Lett. 2016. PMID: 27019033. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Sunifiram Powder

Zeeshan Tariq — Fri, 11 Sep 2026 16:12:30 +0000

Buy Sunifiram Powder Online

Sunifiram, also known as DM235, is a synthetic nootropic compound structurally related to the racetam family. It has primarily been studied in animal models of memory and learning and has attracted attention for its effects on glutamatergic signaling.

Product Information

Preclinical research has demonstrated antiamnesic effects of Sunifiram in several animal models. The available evidence remains predominantly preclinical, with no established human therapeutic use or validated human dosage.

How It Works

Sunifiram appears to influence AMPA-related glutamatergic signaling and other neuronal pathways involved in memory formation. Its precise molecular mechanism remains incompletely established.

POTENTIAL BENEFITS

1. Memory Research

Sunifiram has produced antiamnesic effects in animal models, including models where memory was impaired by scopolamine and other pharmacological challenges.

2. Learning Research

The compound has been investigated for its ability to preserve learning performance under experimentally induced cognitive impairment.

3. Glutamatergic Signaling

Sunifiram's relationship with AMPA-mediated signaling has made it interesting for researchers investigating excitatory neurotransmission and synaptic plasticity.

4. Nootropic Research

Its structural relationship to racetams and pronounced effects in preclinical memory models have made Sunifiram a notable research compound within the nootropic field.

Dosage

There is no established human dosage for Sunifiram. Published research includes very small animal doses, but these should not be converted into human dosing recommendations.

Side Effects

Human safety data are extremely limited. Potential neurological, cardiovascular, or behavioral effects cannot be reliably predicted from the available animal literature, particularly with repeated or high exposure.

References

Ghelardini C, et al. DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer. Naunyn Schmiedebergs Arch Pharmacol. 2002;366(5):462-471. PMID: 12070754. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Coluracetam Powder

Zeeshan Tariq — Fri, 11 Sep 2026 16:12:29 +0000

Buy Coluracetam Powder Online

Coluracetam is a synthetic racetam compound originally investigated for cognitive disorders and later explored in major depressive disorder with anxiety. It is particularly notable for its proposed influence on high-affinity choline uptake.

Product Information

Coluracetam, also known as MKC-231 or BCI-540, reached human clinical development, including Phase 2 research. Available evidence is considerably smaller than for established medicines, and development for its investigated psychiatric indications was discontinued.

How It Works

Coluracetam is primarily associated with modulation of the high-affinity choline uptake system. This pathway helps neurons acquire choline for acetylcholine synthesis and has therefore been investigated in relation to memory and cognitive signaling.

POTENTIAL BENEFITS

1. Cholinergic Research

Coluracetam's distinctive pharmacology centers on high-affinity choline uptake, making it particularly interesting for researchers studying acetylcholine-related neuronal function.

2. Memory Research

Preclinical research has investigated Coluracetam in models of impaired learning and memory, especially where cholinergic neuronal function is disrupted.

3. Cognitive Function

The compound has been explored as a potential cognitive enhancer, although evidence supporting cognitive benefits in healthy humans remains limited.

4. Mood-Related Research

Coluracetam progressed into clinical research for major depressive disorder with concomitant anxiety, demonstrating that its development extended beyond traditional nootropic research.

Dosage

Human clinical-development programs have included oral dosing studies, but there is no established general therapeutic dosage for Coluracetam. Experimental doses from animal studies should not be converted directly into human dosing.

Side Effects

Human safety information is limited. Potential concerns include headache, gastrointestinal effects, insomnia, agitation, or other CNS effects, while the long-term safety profile remains insufficiently characterized.

References

Dutta A, McKie S, Deakin JFW. Ketamine and other potential glutamate antidepressants. Psychiatry Res. 2015;225(1-2):1-13. PMID: 25467702. PubMed
National Center for Advancing Translational Sciences. Coluracetam. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.